Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. NTLA
NTLA logo

NTLA

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

NTLA News

Shopify and Others Tumble as Cathie Wood Buys on Dip

4d agoFool

Intellia Therapeutics to Participate in Upcoming Investor Conferences

5d agoNewsfilter

Latest Developments in the Biotech Sector

Apr 30 2026NASDAQ.COM

ARK Invest Increases Holdings in Robinhood and Others Amid Stock Declines

Apr 30 2026Yahoo Finance

Intellia Therapeutics Prices $180M Public Offering

Apr 29 2026seekingalpha

ARK Investment Management Increases NTLA Holdings

Apr 28 2026stocktwits

Intellia Reports Positive Phase 3 Results for Lonvo-z in Hereditary Angioedema

Apr 28 2026NASDAQ.COM

Intellia Therapeutics Launches $150M Public Offering

Apr 27 2026seekingalpha

NASDAQ 100 Pre-Market Activity Overview

Apr 27 2026NASDAQ.COM

Intellia Achieves Breakthrough in Rare Genetic Condition Treatment

Apr 27 2026stocktwits

Intellia's Gene Editing Therapy Trial Achieves Success

Apr 27 2026CNBC

Intellia Initiates BLA Submission for Lonvo-z in HAE Treatment

Apr 27 2026Newsfilter

Stock Index Futures Dip as Big Tech Earnings Approach Amid U.S.-Iran Uncertainty

Apr 27 2026seekingalpha

Trump Cancels Diplomatic Mission to Pakistan Amid Geopolitical Tensions

Apr 27 2026stocktwits

Intellia's CRISPR Treatment Approaches Key Phase 3 Trial Results

Apr 27 2026stocktwits

US Stock Futures Decline Amid Oil Price Surge

Apr 27 2026stocktwits